• News

"Game of Crohn’s… and Colitis" - Maria T. Abreu, MD

  • GI & Hepatology News
  • New York, NY
  • (July 26, 2018)

The field of inflammatory bowel disease (IBD) is rapidly moving, from the power of the microbiome to the prediction of IBD and new ways to use the established drugs. Although there have been advances in therapy, there have been missed opportunities to prevent long-term complications. At Digestive Disease Week, Jean-Frederic Colombel, MD, professor of medicine and gastroenterology at the Icahn School of Medicine at Mount Sinai and director of the Susan and Leonard IBD Clinical Center at Mount Sinai, presented data of PREDICTS study, in which serum samples collected from military recruits prior to development of IBD was used to identify the serologic markers that could predict those who ultimately developed Crohn’s disease but not UC. These studies provide a proof of concept that may someday be able to be used for personalized approached to treating IBD.

 - Jean-Frédéric Colombel, MD, Professor, Medicine, Gastroenterology, Icahn School of Medicine at Mount Sinai, Director, Susan and Leonard Feinstein IBD Clinical Center at Mount Sinai

Learn more